塩野義薬（4507）　Shionogi Announces Post-Exposure Prophylaxis Results for XOFLUZA(R) in PhaseIII Study (BLOCKSTONE) of Influenza Virus Infection in Household Members 2019/09/02
/-
読み込み中…